Russell Investments Group
ATYR

Russell Investments Group’s aTyr Pharma ATYR Stock Holding History

Russell Investments Group’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,361
Closed -$8.86K – 4541
2026
Q1 		$8.86K Buy
11,361
+4,156
+58% +$3.51K ﹤0.01% 3812
2025
Q4 		$5.64K Sell
7,205
-259
-3% -$213 ﹤0.01% 3893
2025
Q3 		$5.38K Buy
+7,464
New +$33.8K ﹤0.01% 3895
2017
Q1 		– Sell
-1,843
Closed -$59K – 3094
2016
Q4 		$59K Buy
+1,843
New +$75.6K ﹤0.01% 2957

Other funds holding ATYR

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
HWM
Hohimer Wealth Management Seattle, Washington $1B AUM 33.02% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return

Russell Investments Group's ATYR Position: Q2 2026 in Review

Russell Investments Group sold out of aTyr Pharma (ATYR) in Q2 2026, closing a stake of 11,361 shares — an estimated $8.86K sold.

Russell Investments Group first reported a position in ATYR in Q4 2016 and held it in 4 quarters. The position peaked at $59K in Q4 2016. 27 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Russell Investments Group reported no remaining aTyr Pharma position as of Q2 2026 after selling out during the quarter.
  • Russell Investments Group sold 11,361 aTyr Pharma shares in Q2 2026, an estimated $8.86K.
  • Russell Investments Group first reported a position in aTyr Pharma in Q4 2016 and held it in 4 quarters.
  • Russell Investments Group's aTyr Pharma position peaked at $59K in Q4 2016.
  • 27 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.